Connect with us

CBD News

CBD Ads Testing in Google’s Trial Program Begin According to Chilyo, a Cannabidiol Skincare Line

Published

on

CBD Ads Testing in Google's Trial Program Begin According to Chilyo, a Cannabidiol Skincare Line

With the recent clamor about cannabidiol products, Google is starting to review its prohibition on these products in their advertisements. According to a seller of CBD products, companies interested can pay to advertise in this platform with one restriction – to not use the term ‘CBD’ in the advertisements.

Google, the world-famous search engine used to prohibit companies with CBD in their products from advertising in their portals. CBD was listed under its unapproved pharmaceuticals and supplements category which led retailers and distributors relying on search engine optimization.

Shedrack Anderson, co-founder of the CBD-infused skincare line Chllyo LP, said that Google has invited him to participate in the trial of this project. Participants are able to buy advertising through the Google Ads portal. However, Anderson did not state how many retailers are part of this program or when Google plants to introduce this to the public.

Anderson when on to say that just recently, Chilyo was able to submit advertisements for review to Google’s Ads platforms. This is to check if sellers are following regulations such as “no use of the term ‘CBD’” in their ads. According to the CEO, Google urged him to use phrases such as “full-spectrum hemp” to replace CBD names.

In a recent statement made by a Google representative, the prohibition of sellers advertising CBD products is still in effect and that the trial program is not being made.

CBD – A Booming Industry

In 2018, the industry value of CBD was estimated to be $1.9 billion. But in the recent forecast of BDS Analytics, the industry can reach a valuation of $20 billion by 2024. Add this to the tetrahydrocannabinol (THC) products, and this can spike up to $45 billion.

However, there is confusion on the advertisement of CBD products. The 2018 Farm Bill lifted the ban on industrial hemp, but the Drug Enforcement Administration’s list of controlled substances still has cannabidiol.

But where advertising is concerned, Google is not the only platform imposing strict guidelines on CBD advertisements. Facebook Inc.’s regulations are as strict taking down advertisements that have CBD in their products. Likewase, the company prohibits the sale of marijuana and non-medical drugs. As Facebook owns Instagram, these regulations also apply. To add to that, Amazon.com Inc. also doesn’t allow for CBD products or CBD-infused products to be advertised on their site.

Google is forecasted to be the world’s largest digital ad seller this year with a market share of 31.3% in global ad spending which is equivalent to $103.73 based on eMarketer. Currently, Google has suffered a slow growth in the first quarter of 2019 with just 17%. This is the slowest growth the company has seen since 2015.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.